saplin

Compare funds

HDFC Small Cap vs Quant Small Cap

Both are small cap funds. Over the last 3 years HDFC Small Cap returned 9.5% a year and Quant Small Cap 16.7%, against a category median of 14.1%. HDFC Small Cap costs 0.79% a year and Quant Small Cap 0.96%. On the saplin Score HDFC Small Cap rates 4.5 (Weak) and Quant Small Cap 6.2 (Neutral) within their category. 4.3% of their money is in the same stocks.

Direct plans, growth option. Returns and risk as of 15 Nov 2026; past performance does not tell you future returns. See both side by side with charts.

At a glance

HDFC Small CapQuant Small CapCategory median
saplin Score (0–10)4.5 Weak6.2 Neutral—
1-year return-4.3%11.3%8.9%
3-year return, a year9.5%16.7%14.1%
5-year return, a year13.4%17.1%14.1%
Volatility (standard deviation)17.7%20.4%20.1%
Sharpe ratio0.260.570.47
Beta0.780.880.88
Upside capture759589
Downside capture787981
Expense ratio (Direct)0.79%0.96%0.91%
Fund size₹41,670 cr₹35,054 cr₹5,300 cr
Number of holdings8810783
Top 10 holdings, share of fund26.9%36.7%26.9%
Portfolio P/E21.730.431.3
Lead managerChirag Setalvad (12 yrs)——
Launched3 Apr 200823 Sept 1996—

Green marks the higher return, Sharpe ratio, upside capture and Score, and the lower volatility, downside capture and cost. That is the direction of each measure, not a recommendation.

Portfolio overlap

HDFC Small Cap and Quant Small Cap have 4.3% of their portfolios in the same stocks (9 holdings in common, portfolios as of 30 Oct 2026). Overlap is the smaller of the two weights in each shared holding, added up: 100% would be identical portfolios.

Biggest shared holdingsHDFC Small CapQuant Small Cap
Aster DM Quality Care3.45%2.15%
Usha Martin0.77%1.41%
Gabriel India3.36%0.36%
Redington1.14%0.31%
Sonata Software1.16%0.28%
Emami0.31%0.17%
Triveni Turbine0.15%0.13%
SULA VINEYARDS0.19%0.08%
Sudarshan Chemical Industries1.48%0.06%

The funds

How the Score works: methodology. Check any set of funds with the overlap checker.

More comparisons

saplin is not registered with SEBI. This page compares published data and is not a recommendation to buy, hold or sell either fund.